Celera Group (CRA)

HEALTH CARE: PHARMACEUTICALS
SIC: LABORATORY ANALYTICAL INSTRUMENTS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

301 MERRITT 7 NORWALK, CT 06851

Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a segment which includes other activities under corporate management (Corporate). Its Lab Services business, conducted through Berkeley HeartLab, Inc., (BHL), offers a portfolio of clinical laboratory tests and disease management services to help healthcare providers improve cardiovascular disease treatment regimens for patients. Its Products business develops, manufactures, and oversees the commercialization of molecular diagnostic products, which are commercialized through its relationship with Abbott Molecular, a subsidiary of Abbott Laboratories. On July 1, 2008, Celera announced that it has completed its split-off from Applera Corporation.

View SEC Filings from CRA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

AYERS RICHARD H

  • Director
No longer subject to file 2011-05-17 0

BELINGARD JEAN-LUC

  • Director
No longer subject to file 2011-05-17 0

ORDONEZ KATHY CEO AND DIRECTOR

  • Officer
  • Director
No longer subject to file 2011-05-17 0

GREEN WILLIAM G

  • Director
No longer subject to file 2011-05-17 0

SHAPIRO BENNETT M

  • Director
No longer subject to file 2011-05-17 0

NAUGHTON GAIL K

  • Director
No longer subject to file 2011-05-17 0

WHITE THOMAS J SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2011-05-17 0

SIAS STACEY R SVP, BUS DEV & STRATEGIC PLANN

  • Officer
No longer subject to file 2011-05-17 0

ZOCCOLI MICHAEL A. SVP, PRODUCTS GROUP

  • Officer
No longer subject to file 2011-05-17 0

LEE VICTOR VP, CIPC & ASST. SEC.

  • Officer
No longer subject to file 2011-05-17 0

ARATA PAUL D SVP, HR & ADMINISTRATION

  • Officer
No longer subject to file 2011-05-17 0

HUTT PETER BARTON

  • Director
No longer subject to file 2011-05-17 0

MILSTEN SCOTT SVP, GNRL COUNSEL & CORP SEC

  • Officer
No longer subject to file 2011-05-17 0

ROE WAYNE I

  • Director
No longer subject to file 2011-05-17 0

MERCER MICHAEL W. SENIOR VP, BERKELEY HEARTLAB

  • Officer
No longer subject to file 2011-05-17 0

MERRIWEATHER ALFRED G SVP, CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2011-05-17 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BVF X LLC

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
76,511,868 2011-05-13 0

QUEST DIAGNOSTICS INC

SPARK ACQUISITION CORP

  • 10% Owner
107,186,242 2011-05-12 0

BVF X LLC

  • SEE EXPLANATION OF RESPONSES
10,000 2011-05-02 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
45,975,268 2011-04-20 0

DEBLASI UGO D SVP, CHIEF FINANCIAL OFFICER

  • Officer
13,347 2010-08-12 0

HALL CHRISTOPHER M CHIEF BUSINESS OFFICER

  • Officer
36,001 2009-08-12 0

JUNG JOEL R VP, CFO & TREASURER

  • Officer
36,850 2008-08-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments